Vaxart, Inc. Files 8-K with Shareholder Votes and Disclosures
Ticker: VXRT · Form: 8-K · Filed: Jun 17, 2025 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, regulatory-filing, disclosure
Related Tickers: VXRT
TL;DR
Vaxart dropped an 8-K on Friday covering shareholder votes and Reg FD stuff. Check it.
AI Summary
Vaxart, Inc. filed an 8-K on June 17, 2025, reporting on matters submitted to a vote of security holders and providing a Regulation FD disclosure. The filing also includes financial statements and exhibits. The earliest event reported in the filing is June 13, 2025.
Why It Matters
This 8-K filing provides important updates on Vaxart's corporate governance and regulatory compliance, which can influence investor decisions.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- June 13, 2025 (date) — Earliest event reported
- June 17, 2025 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Vaxart, Inc. security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the purpose of the Regulation FD Disclosure mentioned in the filing?
The Regulation FD Disclosure is intended to ensure that material non-public information is broadly disseminated to the public, preventing selective disclosure.
When was Vaxart, Inc. incorporated, and in which state?
Vaxart, Inc. was incorporated in Delaware.
What were Vaxart, Inc.'s former names and when did the name changes occur?
Vaxart, Inc. was formerly known as Aviragen Therapeutics, Inc. (20160413), Biota Pharmaceuticals, Inc. (20121113), and NABI BIOPHARMACEUTICALS (20100719).
What is Vaxart, Inc.'s business address and phone number?
Vaxart, Inc.'s business address is 170 Harbor Way, Suite 300, South San Francisco, CA 94080, and their business phone number is (650) 550-3500.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Vaxart, Inc. (VXRT).